OtherArticle
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 (NQO1) to more potent heat shock protein 90 (Hsp90) inhibitors, the hydroquinone ansamycins
Wenchang Guo, Philip Reigan, David Siegel, Joseph Zirrolli, Daniel Gustafson and David Ross
Molecular Pharmacology July 7, 2006, DOI: https://doi.org/10.1124/mol.106.025643
Wenchang Guo
Philip Reigan
David Siegel
Joseph Zirrolli
Daniel Gustafson
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 (NQO1) to more potent heat shock protein 90 (Hsp90) inhibitors, the hydroquinone ansamycins
Wenchang Guo, Philip Reigan, David Siegel, Joseph Zirrolli, Daniel Gustafson and David Ross
Molecular Pharmacology July 7, 2006, DOI: https://doi.org/10.1124/mol.106.025643
OtherArticle
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 (NQO1) to more potent heat shock protein 90 (Hsp90) inhibitors, the hydroquinone ansamycins
Wenchang Guo, Philip Reigan, David Siegel, Joseph Zirrolli, Daniel Gustafson and David Ross
Molecular Pharmacology July 7, 2006, DOI: https://doi.org/10.1124/mol.106.025643
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement